New targets for drug discovery against malaria.

A mathematical model which predicts the intraerythrocytic stages of Plasmodium falciparum infection was developed using data from malaria-infected mice. Variables selected accounted for levels of healthy red blood cells, merozoite (Plasmodium asexual phase) infected red blood cells, gametocyte (Plas...

Full description

Bibliographic Details
Main Authors: Guido Santos, Néstor V Torres
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3610898?pdf=render
_version_ 1819012936972107776
author Guido Santos
Néstor V Torres
author_facet Guido Santos
Néstor V Torres
author_sort Guido Santos
collection DOAJ
description A mathematical model which predicts the intraerythrocytic stages of Plasmodium falciparum infection was developed using data from malaria-infected mice. Variables selected accounted for levels of healthy red blood cells, merozoite (Plasmodium asexual phase) infected red blood cells, gametocyte (Plasmodium sexual phase) infected red blood cells and a phenomenological variable which accounts for the mean activity of the immune system of the host. The model built was able to reproduce the behavior of three different scenarios of malaria. It predicts the later dynamics of malaria-infected humans well after the first peak of parasitemia, the qualitative response of malaria-infected monkeys to vaccination and the changes observed in malaria-infected mice when they are treated with antimalarial drugs. The mathematical model was used to identify new targets to be focused on drug design. Optimization methodologies were applied to identify five targets for minimizing the parasite load; four of the targets thus identified have never before been taken into account in drug design. The potential targets include: 1) increasing the death rate of the gametocytes, 2) decreasing the invasion rate of the red blood cells by the merozoites, 3) increasing the transformation of merozoites into gametocytes, 4) decreasing the activation of the immune system by the gametocytes, and finally 5) a combination of the previous target with decreasing the recycling rate of the red blood cells. The first target is already used in current therapies, whereas the remainders are proposals for potential new targets. Furthermore, the combined target (the simultaneous decrease of the activation of IS by gRBC and the decrease of the influence of IS on the recycling of hRBC) is interesting, since this combination does not affect the parasite directly. Thus, it is not expected to generate selective pressure on the parasites, which means that it would not produce resistance in Plasmodium.
first_indexed 2024-12-21T01:51:59Z
format Article
id doaj.art-494fdb77203440f2932e0ca558e2f93d
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T01:51:59Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-494fdb77203440f2932e0ca558e2f93d2022-12-21T19:19:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5996810.1371/journal.pone.0059968New targets for drug discovery against malaria.Guido SantosNéstor V TorresA mathematical model which predicts the intraerythrocytic stages of Plasmodium falciparum infection was developed using data from malaria-infected mice. Variables selected accounted for levels of healthy red blood cells, merozoite (Plasmodium asexual phase) infected red blood cells, gametocyte (Plasmodium sexual phase) infected red blood cells and a phenomenological variable which accounts for the mean activity of the immune system of the host. The model built was able to reproduce the behavior of three different scenarios of malaria. It predicts the later dynamics of malaria-infected humans well after the first peak of parasitemia, the qualitative response of malaria-infected monkeys to vaccination and the changes observed in malaria-infected mice when they are treated with antimalarial drugs. The mathematical model was used to identify new targets to be focused on drug design. Optimization methodologies were applied to identify five targets for minimizing the parasite load; four of the targets thus identified have never before been taken into account in drug design. The potential targets include: 1) increasing the death rate of the gametocytes, 2) decreasing the invasion rate of the red blood cells by the merozoites, 3) increasing the transformation of merozoites into gametocytes, 4) decreasing the activation of the immune system by the gametocytes, and finally 5) a combination of the previous target with decreasing the recycling rate of the red blood cells. The first target is already used in current therapies, whereas the remainders are proposals for potential new targets. Furthermore, the combined target (the simultaneous decrease of the activation of IS by gRBC and the decrease of the influence of IS on the recycling of hRBC) is interesting, since this combination does not affect the parasite directly. Thus, it is not expected to generate selective pressure on the parasites, which means that it would not produce resistance in Plasmodium.http://europepmc.org/articles/PMC3610898?pdf=render
spellingShingle Guido Santos
Néstor V Torres
New targets for drug discovery against malaria.
PLoS ONE
title New targets for drug discovery against malaria.
title_full New targets for drug discovery against malaria.
title_fullStr New targets for drug discovery against malaria.
title_full_unstemmed New targets for drug discovery against malaria.
title_short New targets for drug discovery against malaria.
title_sort new targets for drug discovery against malaria
url http://europepmc.org/articles/PMC3610898?pdf=render
work_keys_str_mv AT guidosantos newtargetsfordrugdiscoveryagainstmalaria
AT nestorvtorres newtargetsfordrugdiscoveryagainstmalaria